Abstract
Recent studies have shown that healed plaque at the culprit lesion detected by optical coherence tomography (OCT) is a sign of pan-vascular vulnerability and advanced atherosclerosis. However, the clinical significance of healed plaque is unknown. A total of 265 patients who had OCT imaging of a culprit vessel and 2-year clinical follow-up data were included. Patients were stratified based on the presence or absence of a layered plaque phenotype, defined as layers of different optical density by OCT at either culprit or non-culprit lesions. The association between layered plaque and major adverse cardiac events (MACE), defined as cardiac death, acute coronary syndromes (ACS), or revascularization, was studied. Among 265 patients, 96 (36.2%) had the layered plaque phenotype. Layered plaque was more frequently observed in stable angina pectoris patients than in ACS patients (57.8%vs. 25.1%, p < 0.001). The average clinical follow-up period was 672 ± 172 days. Cumulative MACE was significantly higher in patients with layered plaque (p = 0.041), which was primarily driven by the high revascularization rate at 2 years (p = 0.002). Multivariate regression analysis showed that presence of layered plaque and low-density lipoprotein cholesterol levels were independently associated with an increased risk of revascularization (p = 0.026, p = 0.008, respectively). Patients with healed plaque in the culprit vessel had a higher incidence of revascularization, as compared to those without healed plaque, at 2 years.
Similar content being viewed by others
References
Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R (2001) Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 103:934–940. https://doi.org/10.1161/01.cir.103.7.934
Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20:1262–1275. https://doi.org/10.1161/01.atv.20.5.1262
Shimokado A, Matsuo Y, Kubo T, Nishiguchi T, Taruya A, Teraguchi I, Shiono Y, Orii M, Tanimoto T, Yamano T, Ino Y, Hozumi T, Tanaka A, Muragaki Y, Akasaka T (2018) In vivo optical coherence tomography imaging and histopathology of healed coronary plaques. Atherosclerosis 275:35–42. https://doi.org/10.1016/j.atherosclerosis.2018.05.025
Fuster V (1995) Elucidation of the role of plaque instability and rupture in acute coronary events. Am J Cardiol 76:24C–33C. https://doi.org/10.1016/s0002-9149(99)80467-6
Fracassi F, Crea F, Sugiyama T, Yamamoto E, Uemura S, Vergallo R, Porto I, Lee H, Fujimoto J, Fuster V, Jang IK (2019) Healed culprit plaques in patients with acute coronary syndromes. J Am Coll Cardiol 73:2253–2263. https://doi.org/10.1016/j.jacc.2018.10.093
Yonetsu T, Kato K, Uemura S, Kim BK, Jang Y, Kang SJ, Park SJ, Lee S, Kim SJ, Jia H, Vergallo R, Abtahian F, Tian J, Hu S, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Yu B, Kakuta T, Jang IK (2013) Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography. Circ Cardiovasc Imaging 6:665–673. https://doi.org/10.1161/CIRCIMAGING.113.000345
Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, Kato K, Yonetsu T, Vergallo R, Hu S, Tian J, Lee H, Park SJ, Jang YS, Raffel OC, Mizuno K, Uemura S, Itoh T, Kakuta T, Choi SY, Dauerman HL, Prasad A, Toma C, McNulty I, Zhang S, Yu B, Fuster V, Narula J, Virmani R, Jang IK (2013) In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 62:1748–1758. https://doi.org/10.1016/j.jacc.2013.05.071
Yamamoto MH, Yamashita K, Matsumura M, Fujino A, Ishida M, Ebara S, Okabe T, Saito S, Hoshimoto K, Amemiya K, Yakushiji T, Isomura N, Araki H, Obara C, McAndrew T, Ochiai M, Mintz GS, Maehara A (2017) Serial 3-vessel optical coherence tomography and intravascular ultrasound analysis of changing morphologies associated with lesion progression in patients with stable angina pectoris. Circ Cardiovasc Imaging. https://doi.org/10.1161/CIRCIMAGING.117.006347
Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (2010) Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30:1282–1292. https://doi.org/10.1161/ATVBAHA.108.179739
Wang C, Hu S, Wu J, Yu H, Pan W, Qin Y, He L, Li L, Hou J, Zhang S, Jia H, Yu B (2019) Characteristics and significance of healed plaques in patients with acute coronary syndrome and stable angina: An in vivo oct and ivus study. EuroIntervention 15:e771–e778. https://doi.org/10.4244/EIJ-D-18-01175
Mann J, Davies MJ (1999) Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 82:265–268. https://doi.org/10.1136/hrt.82.3.265
Uemura S, Ishigami K, Soeda T, Okayama S, Sung JH, Nakagawa H, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y (2012) Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J 33:78–85. https://doi.org/10.1093/eurheartj/ehr284
Hoffmann R, Mintz GS, Mehran R, Pichard AD, Kent KM, Satler LF, Popma JJ, Wu H, Leon MB (1998) Intravascular ultrasound predictors of angiographic restenosis in lesions treated with palmaz-schatz stents. J Am Coll Cardiol 31:43–49. https://doi.org/10.1016/s0735-1097(97)00438-5
Shiran A, Weissman NJ, Leiboff B, Kent KM, Pichard A, Satler LF, Wu H, Leon MB, Mintz GS (2000) Effect of preintervention plaque burden on subsequent intimal hyperplasia in stented coronary artery lesions. Am J Cardiol 86:1318–1321. https://doi.org/10.1016/s0002-9149(00)01234-0
Vergallo R, Porto I, D'Amario D, Annibali G, Galli M, Benenati S, Bendandi F, Migliaro S, Fracassi F, Aurigemma C, Leone AM, Buffon A, Burzotta F, Trani C, Niccoli G, Liuzzo G, Prati F, Fuster V, Jang IK, Crea F (2019) Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability: An in vivo optical coherence tomography study. JAMA Cardiol 4:321–329. https://doi.org/10.1001/jamacardio.2019.0275
Arbab-Zadeh A, Fuster V (2015) The myth of the "vulnerable plaque": Transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol 65:846–855. https://doi.org/10.1016/j.jacc.2014.11.041
Crea F, Liuzzo G (2013) Pathogenesis of acute coronary syndromes. J Am Coll Cardiol 61:1–11. https://doi.org/10.1016/j.jacc.2012.07.064
Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P (2005) Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352:29–38. https://doi.org/10.1056/NEJMoa042000
Bayturan O, Kapadia S, Nicholls SJ, Tuzcu EM, Shao M, Uno K, Shreevatsa A, Lavoie AJ, Wolski K, Schoenhagen P, Nissen SE (2010) Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. J Am Coll Cardiol 55:2736–2742. https://doi.org/10.1016/j.jacc.2010.01.050
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565. https://doi.org/10.1056/NEJMoa021993
Ridker PM (2003) Clinical application of c-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363–369. https://doi.org/10.1161/01.cir.0000053730.47739.3c
Acknowledgements
Dr. Jang’s research was supported by Mr. Michael and Mrs. Kathryn Park and by Mrs. Gill and Mr. Allan Gray. We are grateful to Greg Gheewalla and Iris A. McNulty, RN (Massachusetts General Hospital).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
Dr. Jang has received educational grants from Abbott Vascular. They had no role in the design or conduct of this research. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kurihara, O., Russo, M., Kim, H.O. et al. Clinical significance of healed plaque detected by optical coherence tomography: a 2-year follow-up study. J Thromb Thrombolysis 50, 895–902 (2020). https://doi.org/10.1007/s11239-020-02076-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-020-02076-w